Healthcare winners from AIM!
Results and updates covered here include those of small AIM companies supporting the healthcare sector. As is usual in this sector, material future success is largely dependent on take-up in the United States, where one company in particular appears to be making considerable progress, with its shares doubling in quick time. (Free to read)
Bioventix: troponin gaining momentum
Bioventix (AIM:BVXP), the life sciences groups and a highly unusual listed company, reported the now customary solid results for the year ending 30 June 2021.
Bioventix creates, manufactures and supplies high affinity sheep monoclonal antibodies (SMAs) for use in diagnostic applications and its antibodies are preferred for use when they confer an improved test performance compared to other available antibodies.
The majority of Bioventix antibodies are used on blood-testing machines…
Previous article Next article
